• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    CNO Financial Group Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    6/10/25 7:52:21 AM ET
    $CNO
    Accident &Health Insurance
    Finance
    Get the next $CNO alert in real time by email
    cno-20250610
    0001224608falsetrue00012246082025-06-102025-06-100001224608us-gaap:CommonStockMember2025-06-102025-06-100001224608cno:RightsToPurchaseSeriesEJuniorParticipatingPreferredStockMember2025-06-102025-06-100001224608cno:A5125SubordinatedDebenturesDue2060Member2025-06-102025-06-10


    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549

    FORM 8-K

    CURRENT REPORT
    PURSUANT TO SECTION 13 OR 15(d) OF THE
    SECURITIES EXCHANGE ACT OF 1934

    Date of Report (Date of earliest event reported): June 10, 2025

    CNO Financial Group, Inc.
    (Exact Name of Registrant as Specified in Charter)
     
    Delaware001-3179275-3108137
    (State or Other
    Jurisdiction of Incorporation)
    (Commission File Number)(I.R.S. Employer
    Identification No.)
    11299 Illinois Street
    Carmel, Indiana  46032
    (Address of Principal Executive Offices) (Zip Code)

    (317) 817-6100
    (Registrant's telephone number, including area code)

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
    ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading SymbolName of each exchange on which registered
    Common Stock, par value $0.01 per shareCNONew York Stock Exchange
    Rights to purchase Series F Junior Participating Preferred StockNew York Stock Exchange
    5.125% Subordinated Debentures due 2060CNOpANew York Stock Exchange

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐




    Item 7.01.Regulation FD Disclosure.

    On June 10, 2025, CNO Financial Group, Inc. (the "Company") issued an Investments Briefing presentation.  This presentation and future updates to this presentation will be posted in the Investors section of the Company's website: ir.CNOinc.com. A copy of this information is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

    The information contained in this Current Report on Form 8-K (including Exhibit 99.1) is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section. The information contained in this Current Report on Form 8-K shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing.

    Item 9.01(d).Financial Statements and Exhibits.

    The following materials are furnished as exhibits to this Current Report on Form 8-K:

    99.1
    Investments Briefing - June 2025.
    104Cover Page Interactive Data File (embedded within the Inline XBRL document).



    2




    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
    CNO Financial Group, Inc.
    Date: June 10, 2025
    By:/s/ Joel T. Koehneman
    Joel T. Koehneman
    Senior Vice President and
    Chief Accounting Officer




    3
    Get the next $CNO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CNO

    DatePrice TargetRatingAnalyst
    1/23/2025$38.00Market Perform
    BMO Capital Markets
    4/16/2024$29.00Neutral → Overweight
    Piper Sandler
    1/4/2024$24.00 → $26.00In-line → Underperform
    Evercore ISI
    6/29/2023Mkt Perform
    Raymond James
    9/13/2022$25.00Outperform
    RBC Capital Mkts
    1/26/2022$25.00Hold
    Jefferies
    1/7/2022$27.00 → $28.00Equal-Weight
    Morgan Stanley
    1/5/2022$29.00 → $27.00Overweight → Neutral
    Piper Sandler
    More analyst ratings